What are the side effects of tucatinib/tucatinib?

Tucatinib/Tucatinib is an anti-tumor drug, indicated in combination with trastuzumab and capecitabine for the treatment of advanced unresectable or metastatic human epidermal growth factor (HER2)-positive breast cancer (including brain metastases) who have received ≥1 anti-HER2-based treatment regimens in the setting of metastasis. Tucatinibin combination with trastuzumab for the treatment of RASwild-typeHER 2positive unresectable or metastatic colorectal cancer that has progressed after fluoropyrimidine, oxaliplatin, and irinotecan-based chemotherapy.

Tucatinib(Tucatinib)Common side effects include diarrhea (81%), palmoplantar red blood cell dysesthesia syndrome ( 63%), decreased hemoglobin (59%), nausea (58%), decreased phosphate (57%), elevated bilirubin (47%), elevated alanine aminotransferase (46%), elevated transaminase (< /span>43%), liver toxicity (42%), decreased magnesium content (40%), vomiting (42%) pan>36%), decreased potassium (36%), increased creatinine (33%), stomatitis (32%), decreased sodium (28%), increased alkaline phosphatase (26%), decreased appetite (28%) pan>25%), anemia (21%), rash (20%), joint pain (< span>15%), increased creatinine (14%), weight loss (13%), peripheral neuropathy (13%), nose bleeding (12%), etc. There are generic versions of this medicine in Bangladesh. The retail price of Everest Pharmaceuticals in Bangladesh is about 150 mg 30 tablets 6,000 yuan. The retail price of Ziska Pharmaceuticals in Bangladesh is around 4,500 yuan for 150 mg 30 tablets. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.

xa0

xa0

xa0